3-Cyano-D-Phenylalanine

3-Cyano-D-Phenylalanine is a D-configured phenylalanine analog bearing a nitrile substituent on the aromatic ring, providing a rigid, electron-withdrawing functional handle that is commonly leveraged in structure-activity relationship (SAR) and stereodefined peptide or peptidomimetic design. Its non-proteinogenic character makes it valuable when researchers need a defined aromatic nitrile motif and strict stereochemical control rather than native amino acid incorporation. In synthetic and medicinal chemistry workflows, the nitrile group also supports downstream derivatization and analytical tracking of the incorporated motif.

1. Peptidomimetic Building Block

3-Cyano-D-Phenylalanine is used by medicinal chemistry and peptide drug discovery teams to construct D-amino-acid-containing peptidomimetics and constrained analogs where stereochemistry and side-chain electronics are tuned for binding and selectivity studies. The aromatic nitrile substituent offers a compact, polar functionality that can influence local conformation and interaction patterns in receptor/ligand SAR campaigns, while the D-configuration supports the systematic exploration of stereochemical effects on activity and stability trends in lead optimization. Researchers typically employ it in custom peptide synthesis and analog libraries where the nitrile motif must remain intact through assembly and be carried into final structures for comparative bioactivity profiling.

2. SAR and Structure Probing

3-Cyano-D-Phenylalanine is frequently selected for SAR programs that evaluate how an aryl nitrile group and D-stereochemistry affect potency, binding mode, and physicochemical properties across closely related analog series. Chemical biology groups and medicinal chemists use this building block to introduce a defined, electron-withdrawing substituent on a phenylalanine scaffold, enabling controlled variation of steric and electronic features without changing the overall amino acid backbone identity. Because the nitrile is chemically robust during many standard synthetic transformations, it is also favored when the goal is to keep the structural probe consistent across analogs while other regions of the molecule are modified.

3. Pharmaceutical Intermediate Development

3-Cyano-D-Phenylalanine serves as a stereodefined intermediate for downstream synthesis of aryl-nitrile-containing compounds used in process chemistry and discovery-to-development transitions. In pharmaceutical intermediate development, the D-amino acid scaffold provides a reliable chiral starting point for preparing related fragments, side-chain-modified derivatives, and late-stage building blocks where the nitrile functionality must be preserved for final structure assembly or for subsequent functional group interconversions. Teams in specialty chemical manufacturing and contract synthesis value this reagent when they need a well-defined, chiral aromatic nitrile motif that can be carried through multi-step routes toward candidate scaffolds and reference materials.

1. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics